Qube Research & Technologies LTD Rapt Therapeutics, Inc. Transaction History

Qube Research & Technologies LTD

  • $65.7 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 13, 2023
SELL
$16.34 - $24.66 $1.1 Million - $1.66 Million
-67,348 Reduced 62.83%
39,843 $662,000
Q2 2023

Aug 14, 2023
BUY
$16.06 - $21.61 $121,766 - $163,847
7,582 Added 7.61%
107,191 $2 Million
Q1 2023

May 15, 2023
BUY
$17.19 - $30.8 $1.71 Million - $3.07 Million
99,609 New
99,609 $1.83 Million

Others Institutions Holding RAPT

# of Institutions
104
Shares Held
49.4M
Call Options Held
26.7K
Put Options Held
2.4K
View Full List

About RAPT Therapeutics, Inc.

RAPT Quotes by TradingView
  • Ticker RAPT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 29,656,600
  • Market Cap $34.7M
  • Description
  • RAPT Therapeutics, Inc., a clinical-stage immunology-based biopharmaceutical company, focuses on discovering, developing, and commercializing oral small molecule therapies for patients with unmet needs in oncology and inflammatory diseases. Its lead inflammation drug candidate is RPT193, a C-C motif chemokine receptor 4 (CCR4) antagonist that se...
More about RAPT
Track This Portfolio

Track Qube Research & Technologies LTD Portfolio

Follow Qube Research & Technologies LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Qube Research & Technologies LTD, based on Form 13F filings with the SEC.

News

Stay updated on Qube Research & Technologies LTD with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email